Hardy J J, Thomas C L, Utiger R D
Am J Med Sci. 1986 Oct;292(4):193-7. doi: 10.1097/00000441-198610000-00002.
The conversion of thyroxine (T4) to triiodothyronine (T3) was studied in homogenates and subcellular fractions of 10 human liver specimens obtained postmortem. Preliminary studies indicated that T4 5'-deiodinase activity did not decline in rat liver kept at 5 degrees C for 6 and 24 hr after death. All human liver homogenates but one catalyzed T3 production, although the quantity of T3 produced varied greatly, from 8-fold in the absence of dithiothreitol (DTT) to 100-fold in its presence. The wide variation in activity found may reflect either postmortem loss or premortem decline in enzyme activity due to unrecognized nonthyroidal illness. The amount of T3 produced was dependent on substrate availability, protein concentration, time, pH and temperature, and enzyme activity was greatest in the microsomal fraction. T3 production was stimulated by DTT and inhibited by propylthiouracil (PTU). Thus, human liver T4 5'-deiodinase has properties very similar to the same enzyme in rat liver. These data suggest that results of studies of the effects of nonthyroidal illnesses and drugs on T4 5'-deiodinase activity in rat liver may be extrapolated to humans.
在取自10例尸检后的人类肝脏标本的匀浆和亚细胞组分中研究了甲状腺素(T4)向三碘甲状腺原氨酸(T3)的转化。初步研究表明,大鼠肝脏在死后于5℃保存6小时和24小时,其T4 5'-脱碘酶活性并未下降。除一份标本外,所有人类肝脏匀浆均能催化T3生成,尽管生成的T3量差异很大,在无二硫苏糖醇(DTT)时为8倍,在有DTT时为100倍。所发现的活性的广泛差异可能反映了死后损失或由于未被识别的非甲状腺疾病导致的生前酶活性下降。生成的T3量取决于底物可用性、蛋白质浓度、时间、pH和温度,且酶活性在微粒体组分中最高。T3生成受到DTT刺激,并被丙硫氧嘧啶(PTU)抑制。因此,人类肝脏T4 5'-脱碘酶的特性与大鼠肝脏中的同一种酶非常相似。这些数据表明,关于非甲状腺疾病和药物对大鼠肝脏T4 5'-脱碘酶活性影响的研究结果可能适用于人类。